155 related articles for article (PubMed ID: 1256566)
1. Dopamine release in substantia nigra?
Korf J; Zieleman M; Westerink BH
Nature; 1976 Mar; 260(5548):257-8. PubMed ID: 1256566
[No Abstract] [Full Text] [Related]
2. Activation of the subthalamic nucleus and pedunculopontine tegmentum: does it affect dopamine levels in the substantia nigra, nucleus accumbens and striatum?
Jaffer A; van der Spuy GD; Russell VA; Mintz M; Taljaard JJ
Neurodegeneration; 1995 Jun; 4(2):139-45. PubMed ID: 7583677
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of dopamine in the substantia nigra after antidromic activation.
Korf J; Zieleman M; Westerink BH
Brain Res; 1977 Jan; 120(1):184-7. PubMed ID: 832118
[No Abstract] [Full Text] [Related]
4. Feedback loop or output pathway in striato-nigral fibres?
Garcia-Munoz M; Nicolaou MN; Tulloch IF; Wright AK; Arguthnott GW
Nature; 1977 Jan; 265(5592):363-5. PubMed ID: 834284
[No Abstract] [Full Text] [Related]
5. Effects of drugs on the formation of 3-methoxytyramine, a dopamine metabolite, in the substantia nigra, striatum, nucleus accumbens and tuberculum olfactorium of the rat.
Westerink BH
J Pharm Pharmacol; 1979 Feb; 31(2):94-9. PubMed ID: 33260
[No Abstract] [Full Text] [Related]
6. Somatodendritic release of endogenous dopamine: in vivo dialysis in the A10 dopamine region.
Kalivas PW; Bourdelais A; Abhold R; Abbott L
Neurosci Lett; 1989 May; 100(1-3):215-20. PubMed ID: 2761771
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of dopamine metabolism in solid fetal substantia nigra transplants and their terminals in the host striatum.
Meloni R; Gale K
Prog Brain Res; 1990; 82():467-71. PubMed ID: 2127112
[No Abstract] [Full Text] [Related]
8. In vivo release of dopamine from rat striatum, substantia nigra and prefrontal cortex: differential modulation by baclofen.
Santiago M; Machado A; Cano J
Br J Pharmacol; 1993 Jul; 109(3):814-8. PubMed ID: 7689406
[TBL] [Abstract][Full Text] [Related]
9. Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administration.
Csernansky JG; Barnes DE; Bellows EP; Lombrozo L
Life Sci; 1990; 46(10):707-13. PubMed ID: 2314192
[TBL] [Abstract][Full Text] [Related]
10. Increased dopamine metabolism in rat striatum after infusions of substance P into the substantia nigra.
Waldmeier PC; Kam R; Stöcklin K
Brain Res; 1978 Dec; 159(1):223-7. PubMed ID: 728796
[No Abstract] [Full Text] [Related]
11. Striatal 3-methoxytyramine as an index of dopamine release effects of electrical stimulation.
Wood PL; Nair NP; Bozarth M
Neurosci Lett; 1982 Oct; 32(3):291-4. PubMed ID: 6294566
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover.
Hallman H; Jonsson G
Med Biol; 1984; 62(3):198-209. PubMed ID: 6492900
[TBL] [Abstract][Full Text] [Related]
13. Lack of a high affinity transport system for dopamine in the median eminence and posterior pituitary.
Demarest KT; Moore KE
Brain Res; 1979 Aug; 171(3):545-51. PubMed ID: 476488
[No Abstract] [Full Text] [Related]
14. Cobalt injections into the substantia nigra of the rat: effects on behavior and dopamine metabolism in the striatum.
Shibuya M; Fariello R; Farley IJ; Price KS; Lloyd KG; Hornykiewicz O
Exp Neurol; 1978 Feb; 58(3):486-99. PubMed ID: 620704
[No Abstract] [Full Text] [Related]
15. Bilateral dopamine metabolism in the striatum after unilateral application of tetrodotoxine in the midbrain of the rat.
Korf J; Postema F
Brain Res; 1980 Apr; 187(1):251-5. PubMed ID: 7357473
[No Abstract] [Full Text] [Related]
16. Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra.
Dentresangle C; Le Cavorsin M; Savasta M; Leviel V
Brain Res; 2001 Mar; 893(1-2):178-85. PubMed ID: 11223005
[TBL] [Abstract][Full Text] [Related]
17. Effects of a short period of vitamin E-deficient diet in the turnover of different neurotransmitters in substantia nigra and striatum of the rat.
Castaño A; Herrera AJ; Cano J; Machado A
Neuroscience; 1993 Mar; 53(1):179-85. PubMed ID: 7682297
[TBL] [Abstract][Full Text] [Related]
18. Changes in brain cholecystokinin octapeptide following lesions of the medial forebrain bundle.
Williams RG; Gayton RJ; Zhu WY; Dockray GJ
Brain Res; 1981 May; 213(1):227-30. PubMed ID: 6263411
[No Abstract] [Full Text] [Related]
19. Spinal cord dopaminergic neurons: evidence for an uncrossed nigrospinal pathway.
Commissiong JW; Gentleman S; Neff NH
Neuropharmacology; 1979 Jun; 18(6):565-8. PubMed ID: 481709
[No Abstract] [Full Text] [Related]
20. An investigation of dopaminergic metabolites in the striatum and in the substantia nigra in vivo utilising radiolabelled L-DOPA and high performance liquid chromatography: a new approach in the search for transmitter metabolites.
Niazi Shahabi H; Bergquist F; Nissbrandt H
Neuroscience; 2003; 120(2):425-33. PubMed ID: 12890512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
